Advanced search
Publication Cover
Research and Reports in Urology Volume 12, 2020 - Issue
Submit an article Journal homepage
126
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Organ-Specific Therapeutic Effect of Paclitaxel and Carboplatin Chemotherapy After Platinum-Based Chemotherapy and Pembrolizumab for Metastatic Urothelial Carcinoma

Nobuki FurubayashiDepartment of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9159-493XView further author information
ORCID Icon,
Takahito NegishiDepartment of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, JapanView further author information
,
Akihiro MiuraDepartment of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, JapanView further author information
,
Nobutaka NakamuraDepartment of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, JapanView further author information
&
Motonobu NakamuraDepartment of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, JapanView further author information
Pages 455-461 | Published online: 09 Oct 2020

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Nobuki Furubayashi, Takahito Negishi, Naotaka Sakamoto, Hozumi Shimokawa, Futoshi Morokuma, Yoohyun Song, Yoshifumi Hori, Toshihisa Tomoda, Noriaki Tokuda, Narihito Seki, Kentaro Kuroiwa & Motonobu Nakamura. (2021) Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy. OncoTargets and Therapy 14, pages 1981-1988.
Read now

Articles from other publishers (1)

Sara Elena Rebuzzi, Giuseppe Luigi Banna, Veronica Murianni, Alessandra Damassi, Emilio Francesco Giunta, Filippo Fraggetta, Ugo De Giorgi, Richard Cathomas, Pasquale Rescigno, Matteo Brunelli & Giuseppe Fornarini. (2021) Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current Evidence. Cancers 13:21, pages 5517.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.